ArticleAmerican journal of hematology2023

Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.

Andrew H Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.